Inhibition of synaptosomal serotonin uptake by Ketalar

Dan C Martin, R. J. Adams, C. A. Watkins

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The effects of the clinical preparation of ketamine, Ketalar and its preservative, benzethonium chloride on [3H]5-hydroxytryptamine uptake were studied using rat brain synaptosomes. Ketalar caused a concentration-dependent inhibition of substrate uptake by the high affinity transport site (I50 = 20.2 ± 2.75 μM) while benzethonium chloride had no effect. Kinetic analysis indicated the inhibition to be competitive with serotonin; the apparent k(m) (54 nM) was increased nearly two-fold at 10 μM ketamine. This action may represent a mechanism involved in ketamine anesthesia.

Original languageEnglish (US)
Pages (from-to)129-132
Number of pages4
JournalResearch Communications in Chemical Pathology and Pharmacology
Volume62
Issue number1
StatePublished - Jan 1 1988

Fingerprint

Ketamine
Serotonin
Benzethonium
Synaptosomes
Rats
Brain
Anesthesia
Kinetics
Substrates

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Toxicology
  • Pharmacology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Inhibition of synaptosomal serotonin uptake by Ketalar. / Martin, Dan C; Adams, R. J.; Watkins, C. A.

In: Research Communications in Chemical Pathology and Pharmacology, Vol. 62, No. 1, 01.01.1988, p. 129-132.

Research output: Contribution to journalArticle

@article{6088a05a70d741dca34b67cb92aa1dd4,
title = "Inhibition of synaptosomal serotonin uptake by Ketalar",
abstract = "The effects of the clinical preparation of ketamine, Ketalar and its preservative, benzethonium chloride on [3H]5-hydroxytryptamine uptake were studied using rat brain synaptosomes. Ketalar caused a concentration-dependent inhibition of substrate uptake by the high affinity transport site (I50 = 20.2 ± 2.75 μM) while benzethonium chloride had no effect. Kinetic analysis indicated the inhibition to be competitive with serotonin; the apparent k(m) (54 nM) was increased nearly two-fold at 10 μM ketamine. This action may represent a mechanism involved in ketamine anesthesia.",
author = "Martin, {Dan C} and Adams, {R. J.} and Watkins, {C. A.}",
year = "1988",
month = "1",
day = "1",
language = "English (US)",
volume = "62",
pages = "129--132",
journal = "Research Communications in Chemical Pathology and Pharmacology",
issn = "0034-5164",
publisher = "PJD Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Inhibition of synaptosomal serotonin uptake by Ketalar

AU - Martin, Dan C

AU - Adams, R. J.

AU - Watkins, C. A.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The effects of the clinical preparation of ketamine, Ketalar and its preservative, benzethonium chloride on [3H]5-hydroxytryptamine uptake were studied using rat brain synaptosomes. Ketalar caused a concentration-dependent inhibition of substrate uptake by the high affinity transport site (I50 = 20.2 ± 2.75 μM) while benzethonium chloride had no effect. Kinetic analysis indicated the inhibition to be competitive with serotonin; the apparent k(m) (54 nM) was increased nearly two-fold at 10 μM ketamine. This action may represent a mechanism involved in ketamine anesthesia.

AB - The effects of the clinical preparation of ketamine, Ketalar and its preservative, benzethonium chloride on [3H]5-hydroxytryptamine uptake were studied using rat brain synaptosomes. Ketalar caused a concentration-dependent inhibition of substrate uptake by the high affinity transport site (I50 = 20.2 ± 2.75 μM) while benzethonium chloride had no effect. Kinetic analysis indicated the inhibition to be competitive with serotonin; the apparent k(m) (54 nM) was increased nearly two-fold at 10 μM ketamine. This action may represent a mechanism involved in ketamine anesthesia.

UR - http://www.scopus.com/inward/record.url?scp=0023775803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023775803&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 129

EP - 132

JO - Research Communications in Chemical Pathology and Pharmacology

JF - Research Communications in Chemical Pathology and Pharmacology

SN - 0034-5164

IS - 1

ER -